ITL Pharma Revenue

Pharmaceutical Manufacturing • Abingdon, Virginia, United States • 1-10 Employees

ITL Pharma revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at ITL Pharma

Keith R Latham

CEO & Chief Scientist

Company overview

Headquarters	26609 Newbanks Road, Abingdon, VA 24202, US
Phone number	+13038930552
Website	itlpharma.com
NAICS	3254
Founded	1996
Employees	1-10

About ITL Pharma

In 1996, Dr. Keith R. Latham founded ITL Pharma, a drug discovery company, and set out to take on major diseases and ailments. Dr. Latham and his team began developing new, better treatments and diagnostics in the areas of Parkinson's Disease, Thyroid Replacement, Cancer Diagnostics, Cancer Therapy, Alzheimer's Disease, Heart Attack Recovery, Attention Deficit/Hyperactivity Disorder, Anti-Inflammatory, Wound-Healing and Tissue Repair, Cell Culture and others; most of which deal with oxidative free-radicals, which are highly reactive chemicals that cause physiologic damage if they are released into the body. Today, ITL has an R&D Pipeline with 38 candidates, addressing nine therapeutic areas. One of these candidates is entering Phase I clinical trials and several are ready for regulatory review. As ITL continues to grow in a global market, our company is searching for strategic partners to further develop our R&D Pipeline and increase sales of current products and chemicals.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

ITL Pharma has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

ITL Pharma has never raised funding before.

Frequently asked questions

ITL Pharma is located in Abingdon, Virginia, US.

You can reach ITL Pharma at +13038930552.

ITL Pharma generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

ITL Pharma has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ITL Pharma was founded in 1996, making it 30 years old. The company has established itself as a significant player in its industry over this time.

ITL Pharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ITL Pharma

Keith R Latham

CEO & Chief Scientist

4.8

40,000 users